Dr. Lorraine Maita, MD
51 John F Kennedy Parkway · Millburn, NJ 07078
5.0(12 Google reviews · 1 in past year)
Menon Medispa & Wellness · 45 Essex Street · Millburn, NJ 07041
5.0· 123 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Menon Medispa & Wellness is a medical spa in Millburn, New Jersey led by Dr. Aditi Menon, MD, who per its website is board certified in Physical Medicine and Rehabilitation. The site lists HydraFacial, Botox, fillers, laser treatments and IV therapy, describes a medically supervised semaglutide program, and mentions monthly memberships with treatment credits. On Google it holds a 5.0-star rating across 123 reviews dating back to 2019, with 33 posted in the past year. Reviewers most often mention the staff and the providers' knowledge.
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-18. Read the reviews themselves on the practice's Google listing.
Rated ★5.0 across 123 Google reviews. Of the 100 reviews we analyzed, 99 (99%) are positive (4–5★) and 1 (1%) are negative (1–2★).
Very few complaints — only 1 negative review, with no recurring theme.
Melanie B.★★★★★2026-09-18Kala the young lady at the front desk has exceptional customer service. My consultation was seemless. Kala answered all my questions and was able to get me in for an appointment right away. Brittany my esthetician was so pleasant and patient. She eased all my fears and told me what she was doing every step of the way. The office was warm and welcoming I knew I had made the right decision and look forward to future appointments 😊
jamillah b.★★★★★2026-09-08Great experience for my first laser hair removal appointment! It was not painful and I was able to sit through it with no problem. I felt very comfortable. Excited to continue my treatments here!
Victoria B.★★★★★2026-08-28Went to Brittany yesterday for my first ever facial in prep for my wedding next month and she was amazing! She explained each step of the process making sure I was comfortable and I had such a relaxing experience. I was worried about a potential reaction due to my rosacea, but my skin is super smooth and glowing today especially after the dermaplaning. I'll definitely be coming back again right before my wedding
Rob O.★★★★★2026-08-26Very accommodating and did a great job on my face I will be returning every month
Taylor v.★★★★★2026-07-31Always a great experience. Receptionist is friendly and accommodating to appointment changes. Staff is professional and knowledgeable
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
51 John F Kennedy Parkway · Millburn, NJ 07078
5.0(12 Google reviews · 1 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs